Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Breast 1

Conditions

Leukemia, Myeloid, Acute 103Leukemia 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 38Lymphoma 29Prostatic Neoplasms 28Leukemia, Monocytic, Acute 26Leukemia, Erythroblastic, Acute 23Congenital Abnormalities 23Leukemia, Myelomonocytic, Acute 22Leukemia, Megakaryoblastic, Acute 21Myelodysplastic Syndromes 17Lymphoma, Non-Hodgkin 17Lymphoma, Follicular 17Lymphoma, Large B-Cell, Diffuse 16Recurrence 14Lymphoma, Large-Cell, Immunoblastic 10Leukemia, Lymphocytic, Chronic, B-Cell 10Leukemia, Biphenotypic, Acute 9Lymphoma, Mantle-Cell 8Burkitt Lymphoma 7Breast Neoplasms 7Anemia, Refractory, with Excess of Blasts 6Neoplasms 5Leukemia, Promyelocytic, Acute 5Hodgkin Disease 5Blast Crisis 5Ovarian Neoplasms 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Eosinophilic, Acute 4Leukemia, Basophilic, Acute 4

Interventions

Amifostine 19Cisplatin 15Radiotherapy 13Etoposide 10Cyclophosphamide 9Carboplatin 8Paclitaxel 7Filgrastim 7Drug Therapy 5Cytarabine 5apatinib 4Methotrexate 4sodium thiosulfate 3Methylprednisolone 3Gemcitabine 3Docetaxel 3sargramostim 2pegfilgrastim 2glucarpidase 2etoposide phosphate 2denileukin diftitox 2camrelizumab 2Voriconazole 2Vincristine 2Social Determinants of Health 2Pyridoxine 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Mitoxantrone 2Melphalan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Mitoxantrone × Clear all
NCT00003407 2023-02-02

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Rush University Medical Center

Phase 2 Withdrawn
MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelodysplastic Syndromes, Neutropenia, Leukemia, Myeloid, Acute, Drug-Related Side Effects and Adverse Reactions

NCT00003068 2013-01-31

High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
Breast

Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡